Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 26, 2025

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
10:38

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver

Published on: May 4, 2016

16.1K

FDA tackles gene-drug interactions

Asher Mullard

    Nature Reviews. Drug Discovery
    |March 13, 2020
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Dec 26, 2025

    In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
    10:38

    In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver

    Published on: May 4, 2016

    16.1K

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    NfL makes regulatory debut as neurodegenerative disease biomarker.

    Nature reviews. Drug discovery·2023
    Same author

    NCATS's plan to grow the rare disease pipeline.

    Nature reviews. Drug discovery·2023
    Same author

    GSK buys purine receptor antagonist for $2 billion.

    Nature reviews. Drug discovery·2023
    Same author

    FDA approves second microbiome-based C. difficile therapy.

    Nature reviews. Drug discovery·2023
    Same author

    Astellas buys complement inhibitor for $5.9 billion.

    Nature reviews. Drug discovery·2023
    Same author

    Setting GPCRs free.

    Nature reviews. Drug discovery·2023